ProAxsis attends The Bio International Convention June 5-8, 2023

One on One partnering image

ProAxsis Ltd is participating in the BIO International Convention One-on-One Partnering™ event being held in Boston, MA from June 5th through the 8th. The One-on-One system will provide opportunities to connect with leaders, investors and innovators across the industry.  ProAxsis CEO David Ribeiro, PhD is attending and is quickly filling up the timeslots for these […]

ProAxsis announces that two of its products, the ProteaseTag® Active NE Immunoassay, and NEATstik®, the first test to enable measurement of active neutrophil elastase at point-of-care, have been selected for inclusion in a major upcoming clinical trial. The BRIDGE study is a 3-year collaborative study, funded by the European Respiratory Society (ERS), in which1000 patients with bronchiectasis across Europe will be recruited and will have multiple assessments including microbiome,proteomics, detailed phenotyping and imaging. The study will explore novel biomarkers and demonstrate what they can add to clinical practice. (Sept 2018)